web analytics
April 23, 2014 / 23 Nisan, 5774
At a Glance

Posts Tagged ‘RHB’

Israeli Anti-Nausea Pill for Cancer Patients Passes Clinical Trial

Tuesday, April 24th, 2012

Israel’s RedHill Biopharma announced success last week in a major clinical trial of a new drug to prevent nausea in cancer patients.

The once-a-day pill RHB-102, which has now passed a trial corresponding to a Phase III clinical trial, will compete with leading anti-nausea drug Zofran, made by GlaxoSmithKline, which is taken several times a day.

Redhill will apply to the FDA for a pre-New Drug Application hearing for market approval in a few weeks.

Anti-nausea medications are estimated to be worth $2 billion around the world, according to a report in Globes online business news.

Printed from: http://www.jewishpress.com/news/breaking-news/israeli-anti-nausea-pill-for-cancer-patients-passes-clinical-trial/2012/04/24/

Scan this QR code to visit this page online: